Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Enrico Buonamico
Omalizumab as Add‐on Therapy in a Patient With Severe Asthma and OSA
Respirology Case Reports
Pulmonary
Respiratory Medicine
Related publications
Reslizumab: Add-On Therapy for Severe Eosinophilic Asthma
Prescriber
Pharmacology
ABS37: Add-On Omalizumab Improves Asthma Control Across Multiple Measures of Response in Patients With Severe Persistent Allergic (IgE-mediated) Asthma
Primary Care Respiratory Journal
Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Phase III Randomized Controlled Trial of Tiotropium Add-On Therapy in Children With Severe Symptomatic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
First Experience With Omalizumab in a Child With Severe Persistent Asthma in Turkey: Case Report
Turkiye Klinikleri Journal of Medical Sciences
Medicine
Efficacy and Tolerability of Atorvastatin as Add on Therapy in the Treatment of Chronic Stable (Moderate-Severe) Asthma for a Duration of 8 Weeks
International Journal of Basic & Clinical Pharmacology
A Review of Omalizumab for the Management of Severe Asthma
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science